eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
10.35
+0.03 (0.24%)
Apr 29, 2026, 4:00 PM EDT - Market closed
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $87.76 million as of April 29, 2026. Its market cap has decreased by -36.18% in one year.
Market Cap
87.76M
Enterprise Value
85.75M
1-Year Change
-36.18%
Ranking
Category
Stock Price
$10.35
Market Cap Chart
Since November 13, 2024, eXoZymes's market cap has increased from $70.30M to $87.76M, an increase of 24.83%. That is a compound annual growth rate of 16.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 87.55M | -4.24% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 95.87M |
| Aldeyra Therapeutics | 95.09M |
| NeurAxis | 93.54M |
| Rani Therapeutics Holdings | 88.82M |
| PolyPid | 87.40M |
| Sangamo Therapeutics | 87.00M |
| Alterity Therapeutics | 86.00M |
| Champions Oncology | 85.82M |